The noninvasive cardiovascular technology HeartFlow FFRct Analysis, which allows clinicians to view a 3D model of a patient's coronary blood flow, will now be covered by seven new commercial payers issuing medical policies, according to a recent article by Cardiovascular Business.
HeartFlow made the announcement that will allow more than 185 million patients to have access to the non-inavsive technology on Feb. 1. The FFRct Analysis system combines results from coronary CT angiograms with computer algorithms to create a "personalized, 3D model of a patient's coronary arteries."
The new payers included Cigna, Florida Blue, Highmark, Independence Blue Cross and the Blue Cross and Blue Shield plans in Michigan, North Carolina and Vermont.
“These positive coverage decisions reinforce the clinical and economic value of the HeartFlow Analysis in addressing how heart disease is diagnosed and treated,” HeartFlow president and CEO John H. Stevens, MD, said in a press release. “With the growing momentum of coverage, a wealth of scientific evidence, and unparalleled technology, the HeartFlow Analysis is poised to become the standard of care for patients with suspected heart disease.”
Read more at Cardiovascular Business: